[Expert guidance and consensus for standardization of lipid profile testing report in China].

Domestic and international guidelines focusing on ASCVD risk stratification and precision treatment of dyslipidemia emphasize the formulation of individualized LDL-C targets based on risk stratification. However, in current clinical practice in China, most lipid profile testing reports adopt a single presentation format, with the indicated reference ranges only applicable to the general healthy population, which fails to meet the needs of stratified treatment for patients with varying risk levels.To promote the precise diagnosis and assessment of dyslipidemia, and improve the treatment rate and long-term compliance rate of dyslipidemia, the Expert Group of Expert guidance and consensus for standardization of lipid profile testing report in China has organized multidisciplinary experts to formulate and issue Expert guidance and consensus for standardization of lipid profile testing report in China. This document provides guidance for the clinical reform of lipid profile testing reports. Through the reform and standardization of lipid profile testing reports, it aims to raise the awareness and attention of cardiologists, non-cardiovascular specialists, and patients with dyslipidemia, improve the awareness and diagnosis rates of dyslipidemia among different populations, and facilitate the implementation of individualized risk assessment and precision treatment regimens. It will also help establish a more scientific and efficient system for lipid management, enhance the efficiency of medical resource utilization, reduce the risk of CVD and the associated burden on medical insurance expenditures, and yield greater public health and economic benefits.